Kingdom Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.9K Sell
1,374
-67
-5% -$2.88K 0.02% 232
2026
Q1
$53K Buy
1,441
+640
+80% +$30.3K 0.02% 270
2025
Q4
$40.8K Buy
+801
New +$41K 0.01% 279

Other funds holding NVO

Kingdom Financial Group's NVO Position: Q2 2026 in Review

Kingdom Financial Group reduced its Novo Nordisk (NVO) stake by 4.6% in Q2 2026, selling an estimated $2.88K and leaving 1,374 shares worth $65.9K. The position accounts for 0.02% of the portfolio, ranked #232.

Kingdom Financial Group first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Kingdom Financial Group held 1,374 shares of Novo Nordisk worth $65.9K as of Q2 2026.
  • Kingdom Financial Group sold 67 Novo Nordisk shares in Q2 2026, an estimated $2.88K.
  • Novo Nordisk made up 0.02% of Kingdom Financial Group's portfolio in Q2 2026, its #232 holding.
  • Kingdom Financial Group first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.